MENU
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NewAmsterdam Pharma (NAMS) Ownership - Who owns NewAmsterdam Pharma?
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more
Profile
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.85B
P/E Ratio
N/A
Total Cash
808.48M
Projected Growth
N/A
Total Debt
389K
Revenue
47.14M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.18
Total Debt/Equity
N/A
Revenue/Share
0.60 USD as % of share price
Fundamentals
NAMS
Capitalization
2.85B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
808M
Total Cash/Share
7.18
Total Debt
389K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.60%
Revenue
47.1M
ROE
N/A
Book Value
777M
P/B Ratio
3.66
Cash Flow
N/A
Earnings
-1.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14M
Current Ratio
19.98
Current Revenue Per Employee
38675.32
Dividends Per Share - Security
N/A
EBITDA
-254.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.67
Shares Held By Institutions
2.6B
Shares Outstanding - Current
113M
Total Liabilities
41M
Total Volume MTD
N/A
Value
-1
Gain YTD
-1.518
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAMS showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com